Literature DB >> 10353720

A highly selective, high-affinity transporter for uracil in Trypanosoma brucei brucei: evidence for proton-dependent transport.

H P de Koning1, S M Jarvis.   

Abstract

The presence of an uptake mechanism for uracil in procyclic forms of the protozoan parasite Trypanosoma brucei brucei was investigated. Uptake of [3H]uracil at 22 degrees C was rapid and saturable and appeared to be mediated by a single high-affinity transporter, designated U1, with an apparent Km of 0.46 +/- 0.09 microM and a Vmax of 0.65 +/- 0.08 pmol x (10(7) cells)(-1) x s(-1). [3H]Uracil uptake was not inhibited by a broad range of purine and pyrimidine nucleosides and nucleobases (concentrations up to 1 mM), with the exception of uridine, which acted as an apparent weak inhibitor (Ki value of 48 +/- 15 microM). Similarly, most chemical analogues of uracil, such as 5-chlorouracil, 3-deazauracil, and 2-thiouracil, had little or no affinity for the U1 carrier. Only 5-fluorouracil was found to be a relatively potent inhibitor of uracil uptake (Ki = 3.2 +/- 0.4 microM). Transport of uracil was independent of extracellular sodium and potassium gradients, as replacement of NaCl in the assay buffer by N-methyl-D-glucamine, KCl, LiCl, CsCl, or RbCl did not affect initial rates of transport. However, the proton ionophore carbonyl cyanide chlorophenylhydrazone inhibited up to 70% of [3H]uracil flux. These data show that uracil uptake in T. b. brucei procyclics is mediated by a single high-affinity transporter with high substrate selectivity and are consistent with a nucleobase-H+-symporter model for this carrier.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10353720     DOI: 10.1139/bcb-76-5-853

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  14 in total

Review 1.  Nucleoside and nucleobase transporters in parasitic protozoa.

Authors:  Scott M Landfear; Buddy Ullman; Nicola S Carter; Marco A Sanchez
Journal:  Eukaryot Cell       Date:  2004-04

Review 2.  Pyrimidine metabolism in schistosomes: A comparison with other parasites and the search for potential chemotherapeutic targets.

Authors:  Mahmoud H El Kouni
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  2017-07-21       Impact factor: 2.231

3.  Comprehensive characterization of purine and pyrimidine transport activities in Trichomonas vaginalis and functional cloning of a trichomonad nucleoside transporter.

Authors:  Manal J Natto; Yukiko Miyamoto; Jane C Munday; Tahani A AlSiari; Mohammed I Al-Salabi; Neils B Quashie; Anthonius A Eze; Lars Eckmann; Harry P De Koning
Journal:  Mol Microbiol       Date:  2021-11-20       Impact factor: 3.501

4.  Characterization of Trypanosoma brucei dihydroorotate dehydrogenase as a possible drug target; structural, kinetic and RNAi studies.

Authors:  Tracy L Arakaki; Frederick S Buckner; J Robert Gillespie; Nicholas A Malmquist; Margaret A Phillips; Oleksandr Kalyuzhniy; Joseph R Luft; George T Detitta; Christophe L M J Verlinde; Wesley C Van Voorhis; Wim G J Hol; Ethan A Merritt
Journal:  Mol Microbiol       Date:  2008-02-26       Impact factor: 3.501

5.  Pyrimidine salvage in Trypanosoma brucei bloodstream forms and the trypanocidal action of halogenated pyrimidines.

Authors:  Juma A M Ali; Darren J Creek; Karl Burgess; Harriet C Allison; Mark C Field; Pascal Mäser; Harry P De Koning
Journal:  Mol Pharmacol       Date:  2012-11-27       Impact factor: 4.436

6.  Functional and genetic evidence that nucleoside transport is highly conserved in Leishmania species: Implications for pyrimidine-based chemotherapy.

Authors:  Khalid J H Alzahrani; Juma A M Ali; Anthonius A Eze; Wan Limm Looi; Daniel N A Tagoe; Darren J Creek; Michael P Barrett; Harry P de Koning
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2017-04-20       Impact factor: 4.077

7.  Positively selected modifications in the pore of TbAQP2 allow pentamidine to enter Trypanosoma brucei.

Authors:  Ali H Alghamdi; Jane C Munday; Gustavo Daniel Campagnaro; Dominik Gurvic; Fredrik Svensson; Chinyere E Okpara; Arvind Kumar; Juan Quintana; Maria Esther Martin Abril; Patrik Milić; Laura Watson; Daniel Paape; Luca Settimo; Anna Dimitriou; Joanna Wielinska; Graeme Smart; Laura F Anderson; Christopher M Woodley; Siu Pui Ying Kelly; Hasan Ms Ibrahim; Fabian Hulpia; Mohammed I Al-Salabi; Anthonius A Eze; Teresa Sprenger; Ibrahim A Teka; Simon Gudin; Simone Weyand; Mark Field; Christophe Dardonville; Richard R Tidwell; Mark Carrington; Paul O'Neill; David W Boykin; Ulrich Zachariae; Harry P De Koning
Journal:  Elife       Date:  2020-08-11       Impact factor: 8.140

8.  Divergent metabolism between Trypanosoma congolense and Trypanosoma brucei results in differential sensitivity to metabolic inhibition.

Authors:  Pieter C Steketee; Emily A Dickie; James Iremonger; Kathryn Crouch; Edith Paxton; Siddharth Jayaraman; Omar A Alfituri; Georgina Awuah-Mensah; Ryan Ritchie; Achim Schnaufer; Tim Rowan; Harry P de Koning; Catarina Gadelha; Bill Wickstead; Michael P Barrett; Liam J Morrison
Journal:  PLoS Pathog       Date:  2021-07-26       Impact factor: 6.823

9.  Pyrimidine biosynthesis is not an essential function for Trypanosoma brucei bloodstream forms.

Authors:  Juma A M Ali; Daniel N A Tagoe; Jane C Munday; Anne Donachie; Liam J Morrison; Harry P de Koning
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

10.  Gene amplification and point mutations in pyrimidine metabolic genes in 5-fluorouracil resistant Leishmania infantum.

Authors:  Jean-François Ritt; Frédéric Raymond; Philippe Leprohon; Danielle Légaré; Jacques Corbeil; Marc Ouellette
Journal:  PLoS Negl Trop Dis       Date:  2013-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.